Join the Hypertrophic Cardiomyopathy group to help and get support from people like you.
Hypertrophic Cardiomyopathy News
Related terms: Cardiomyopathy, hypertrophic, HCM
Experimental Drug Helps Folks Battling Enlarged Heart Move More
FRIDAY, May 17, 2024 – An experimental drug can help patients better live with a genetic condition that causes the heart to enlarge and thicken, a new clinical trial shows. People with the...
Aficamten Beneficial for Obstructive Hypertrophic Cardiomyopathy
THURSDAY, May 16, 2024 – Treatment with the oral selective cardiac myosin inhibitor aficamten results in significantly greater improvement in peak oxygen uptake compared with placebo among patients...
Guidelines Developed for Management of Hypertrophic Cardiomyopathy
THURSDAY, May 9, 2024 – In a new clinical guideline issued by the American College of Cardiology and the American Heart Association and published online May 8 in the Journal of the American College...
ESC: Mavacamten Cuts Need for Septal Reduction Tx with Hypertrophic Cardiomyopathy
TUESDAY, Aug. 29, 2023 – In patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), mavacamten reduces the need for septal reduction therapy (SRT) at week 56, according to a study...
FDA Approves Camzyos (mavacamten) for the Treatment of Symptomatic NYHA Class II-III Obstructive Hypertrophic Cardiomyopathy
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Camzyos (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules)...
Ask a question
To post your own question to this support group, sign in or create an account.